Published on March 22, 2016
Claire Harrison of the Guy's and St. Thomas Hospital in London, UK, talks about pregnancy in patients diagnosed with myeloproliferative neoplasms (MPN). In the UK, clinicians have used the Obstetrics Surveillance System (UKOSS) to collect information on pregnant women with certain conditions, including MPNs. This as served a variety of purposes, it has raised awareness in among obstetricians and gynecologists, and it showed that 70 percent of pregnancies with MPN are successful without risk for the mother and baby. However, this survey also showed an increased risk of early miscarriage and late pregnancy events (for example, pre-eclampsia, small-for-dates babies, early deliveries, and babies with low Apgar scores). Dr Harrison also discusses the steps clinicians take to ensure pregnancies are as successful as possible.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL.